Amyotrophic lateral sclerosis (ALS) is characterized by the pathological aggregation of TDP-43 (TAR DNA-binding protein 43) in motor neurons → NF-κB motoneuronal → neuro-anti-inflammatory-science-utilisation">turmeric-black-pepper-chronic-pain">microglial anti-inflammatory (NLRP3/IL-1β) → progressive death of upper and lower motor neurons. An emerging gut-motor neuron axis shows severe dysbiosis in ALS (↓ Butyrivibrio/Roseburia, ↑ Cyanobacteria) → LPS → spinal TLR4/NF-κB → microgliosis. 6-gingerol inhibits motoneuronal NF-κB, activates Nrf2 (mitochondrial protection) and reduces microglial NLRP3. INTI Elixir: 1.19g sugar per 100ml — minimal inflammatory load in this devastating pathology. ⚠️ ALS is a serious progressive disease — ginger is a nutritional adjuvant, never a treatment. Do not modify riluzole or edaravone without your neurologist.
ALS: Molecular Mechanisms of Motor Neuron Neurodegeneration
ALS affects ~1,000 new cases/year in Belgium (prevalence ~3,000). Median survival 3-5 years after diagnosis. Mechanisms:
- Pathological TDP-43: TDP-43 (transcription/splicing factor) forms ubiquitinated aggregates in the cytoplasm of motor neurons → loss of nuclear function (mRNA regulation) + gain of toxic cytoplasmic function. Present in >97% of sporadic cases (sALS). TDP-43 mutations (TARDBP) cause familial forms.
- Motoneuronal NF-κB: TDP-43 aggregates → cortisol-naturel">ginger ER stress (UPR) → NF-κB → motoneuronal TNF-α/IL-1β → mitochondrial apoptosis. NF-κB is also activated in surrounding astrocytes and microglia → amplified neuroinflammation.
- Microglial NLRP3 ALS: LPS/ATP/TDP-43 aggregates → microglial NLRP3 → IL-1β/IL-18 → astrocytic pyroptosis → glutamate excitotoxicity (NMDA/AMPA → intracellular Ca²⁺ ↑ → motor neuron death).
- Nrf2/mitochondria ALS: Mitochondrial dysfunction central to ALS (SOD1 mutations originally, now TDP-43). Mitochondrial ROS ↑↑ → lipid/protein oxidation → Nrf2 depletion. Riluzole (only long-approved treatment) reduces glutamate release.
- Gut-motor neuron axis: Recent studies (Univ. Columbia 2022, Angiulli/Bhatt): severe ALS dysbiosis predicting progression — ↓ Butyrivibrio fibrisolvens (protective butyrate producer), ↑ Cyanobacteria (BMAA producer — β-methylamino-L-alanine, neurotoxin). Systemic LPS → spinal TLR4/NF-κB → ventral horn microglial activation. ALS microbiome transplantation → motor deterioration in SOD1 models.
Ginger & ALS — Neuroprotective Mechanisms
| ALS Target | Ginger Action | Molecular Mechanism |
|---|---|---|
| Motoneuronal NF-κB | 6-gingerol → IKKβ ↓ | Motoneuronal TNF-α/IL-1β ↓ |
| Microglial NLRP3 | 6-gingerol → NLRP3 assembly ↓ | IL-1β ↓ → glutamate excitotoxicity ↓ |
| Mitochondrial Nrf2/HO-1 | 6-shogaol → Nrf2 activation | Mitochondrial ROS ↓, SOD ↑ |
| LPS → spinal TLR4/NF-κB | Polyphenols → zonulin ↓ → LPS ↓ | Gut-motor neuron axis ↓ |
| Butyrivibrio (butyrate) | Polyphenols → Butyrivibrio ↑ | Butyrate → spinal NF-κB ↓ |
- Riluzole (Rilutek) — metabolized by CYP1A2. Ginger may slightly inhibit CYP1A2 → possible increase in riluzole concentrations. Clinical monitoring. Always validate with the neurologist.
- Edaravone (Radicava) — IV antioxidant, ROS inhibitor. Ginger (Nrf2/HO-1 antioxidant) may have a theoretical synergistic effect. No clinical trials available. Caution.
- Tofersen (Qalsody) — SOD1-ALS antisense therapy approved 2023. No known interactions with ginger.
- ALS Dysphagia — 85% of ALS patients develop dysphagia. INTI must be diluted (3cl in 150ml water). Percutaneous endoscopic gastrostomy (PEG): consult the ALS team for administration methods.
- Ginger does not slow ALS progression — no human clinical trials available. It may improve digestive comfort, associated ginger constipation, and systemic inflammatory profile.
INTI vs GIMBER — ALS
| ALS Criterion | INTI Elixir | GIMBER |
|---|---|---|
| Sugar (NLRP3/NF-κB) | 1.19g/100ml | ~35g/100ml → neuronal NLRP3 fuel |
| Gut-motor neuron axis | Polyphenols → Butyrivibrio ↑, LPS ↓ | Sugar → ALS dysbiosis ↑ |
| Nrf2/antioxidant | 6-shogaol → Nrf2 ↑ | Sugar → accelerated Nrf2 depletion |
| Dysphagia compatibility | Liquid — easily diluted | Problematic sugar load |
FAQ — ALS & Ginger (8 questions)
Q1: Can ginger stop ALS?
No — no treatment stops ALS. Ginger (6-gingerol) can modulate neuroinflammation (NLRP3 ↓, NF-κB ↓) and improve the gut-motor neuron axis, but no human ALS/ginger clinical trials are available. It is a nutritional adjuvant, not a disease-modifying treatment.
Q2: What is TDP-43 and why is it central to ALS?
TDP-43 is a nuclear RNA-binding protein. In ALS (>97% of cases), it forms ubiquitinated cytoplasmic aggregates in motor neurons → loss of mRNA regulation + NF-κB activation + ER stress → progressive motor neuron death.
Q3: What is BMAA and why is it dangerous in ALS?
β-methylamino-L-alanine (BMAA) is a neurotoxin produced by intestinal Cyanobacteria. In ALS, Cyanobacteria ↑ in the microbiome → BMAA → protein misfolding → TDP-43-like aggregates. Sugar (GIMBER 35g) promotes Cyanobacteria growth — doubly problematic in ALS.
Q4: Riluzole and ginger — any interaction to worry about?
Riluzole is metabolized by CYP1A2. Ginger may slightly inhibit CYP1A2 (at high doses). At INTI dose (3cl) this interaction is likely minor but should be reported to the neurologist who monitors riluzole tolerance (transaminases).
Q5: ALS dysphagia — how to use INTI?
Dilute INTI 3cl in 150ml of warm water. Liquid consistency. In severe dysphagia, consult a speech therapist for liquid thickening. After PEG: consult the ALS team for tube administration.
Q6: Is the gut-motor neuron axis really documented in ALS?
Yes — studies from 2019-2023 (Univ. Columbia, NEJM Letters, Front. Neurol.) show specific ALS dysbiosis preceding or correlating with progression. Microbiome transplantation from ALS patients into SOD1 mice accelerates the phenotype. The gut is a real target in ALS.
Q7: Constipation in ALS — can INTI help?
Constipation is common in ALS (progressive immobility, autonomic dysmotility). Ginger (5-HT₄ prokinetic) improves transit. Digestive comfort is a major quality of life issue in ALS.
Q8: Where to find INTI in Belgium for an ALS patient?
INTI available on inti-drink.com and Belgian pharmacies/health stores. Concentrated liquid to dilute — suitable for mild-moderate dysphagia. 1.19g sugar, no liver-proteger-gingembre-lendemain-fete-2026">alcohol.
GIMBER: 35g sugar → neuronal NLRP3 fuel + Cyanobacteria/BMAA ↑ + Nrf2 depletion
INTI: 1.19g sugar → motoneuronal NF-κB ↓ + Butyrivibrio ↑ + Nrf2/HO-1 protection
⚠️ Nutritional adjuvant only — Under neurological supervision
Discover INTI — 1.19g sugar
Related Articles
To learn more, also read:
- ginger and Parkinson's-belgique-alpha-synucleine-nlrp3-dopamine-axe-intestin-brain-ginger-2025">Parkinson's Disease & Ginger: α-Synuclein, NLRP3, Dopamine and Gut-Brain Axis | INTI Belgium
- Autoimmune Hepatitis (AIH) & Ginger: Hepatic NF-κB, Treg and Liver Microbiome | INTI Belgium
- Primary Biliary Cholangitis (PBC) & Ginger: Biliary NF-κB, Bile Acids and Hepatic Microbiome | INTI Belgium
- Dermatomyositis & Polymyositis: IFN-α, Muscular NF-κB, MDA5 and Microbiome | INTI Belgium
- Diabetic Nephropathy & Ginger: Glomerular NF-κB, TGF-β and Renal Microbiome | INTI Belgium
- Belgian Police Officers & Ginger: Chronic Stress, PTSD, ginger cortisol and NF-κB | INTI Belgium
- Psoriatic Arthritis & Ginger: IL-17A, TNF-α, Derm-Joint Axis and Microbiome | INTI Belgium
- POTS & Postural Dysautonomia: Autonomic NF-κB, RAAS and Microbiome | INTI Belgium
Useful INTI Pages
To go further:
- Chronic Inflammation: The Complete Guide (Ginger, NF-kB, Diet)
- INTI for Chronic Inflammation: The Targeted NF-kB Formula
- Best ginger drink 2026: INTI vs GIMBER vs Fever Tree vs KoRo Comparison